In this study, we identified that the SIRT1-PPARγ-MGAT1 axis is critically involved in alcoholic hepatic steatosis, making MGAT1 a potential therapeutic target of hepatic fatty liver disease. This evidence concerns the gene PPARG and fatty liver disease.